New CPT® Code Announced to Report Novel Coronavirus Test
The American Medical Association (AMA) announced that the CPT® Editorial Panel approved a new addition to the Current Procedural Terminology (CPT®) code set that will help streamline data-driven resource planning and allocation in the battle against the novel Coronavirus (SARS-CoV-2) as the number of confirmed COVID-19 cases continues to rise.
Note: It is unlikely that practices are performing the laboratory testing for COVID-19 in the office. This code, however, may need to be used for ordering and documenting the testing and for result-tracking purposes. |
For quick reference, the new Category I CPT code and descriptor are:
- 87635 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique.
The code is effective immediately for use as the industry standard for reporting of tests for the Novel Coronavirus across the nation’s health care system. In addition to the long descriptor, CPT code 87635 has short and medium descriptors that can be accessed on the AMA website.
Note: Per the standard early release delivery process for CPT codes, you will need to manually upload this code descriptor into your OP. If you are unfamiliar with adding new CPT Codes into OP, click here. This CPT code will arrive as part of the complete CPT code set in the data file for 2021 later this year. To read the full press release from the AMA, click here. |
CPT © Copyright 2020 American Medical Association. All rights reserved. AMA and CPT are registered trademarks of the American Medical Association.
